Viking Therapeutics at ObesityWeek 2026

Nov 14–17, 2026 National Harbor, MD ~4.4k attendees Website

Viking Therapeutics at ObesityWeek 2026 in National Harbor: Booth 632, Suite 16.

OrganizationObesityWeek 2026 Attendance
Viking Therapeutics
San Diego, CA
Biotech
Clinical-stage company developing VK2735, a dual GLP-1/GIP receptor agonist in Phase 3 for obesity, in injectable and oral forms.
Booth
Exhibiting at Booth 632, Suite 16
Sat, Nov 147pm–9:30pmSun, Nov 159:30am–4pmMon, Nov 169:30am–4pm

Explore the full ObesityWeek 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in National Harbor. Leave your work email and we’ll be in touch.

Privacy

Download the full ObesityWeek 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Viking Therapeutics

Tell us what you sell and we’ll find the people at Viking Therapeutics most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by The Obesity Society (TOS), ObesityWeek® or the American Society for Metabolic and Bariatric Surgery (ASMBS). Submit a correction